Vimarsana
Biggest News Aggregation in the World

Olivia Manser News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Olivia Manser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Olivia Manser Today - Breaking & Trending Today

Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO - Vimarsana News

Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO

The majority of patients that responded to obe-cel showed durable responses with the potential for a long-term plateau of survival outcomes40% patients are in ongoing remission without subsequent stem...

Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2024 Earnings Call Transcript - Vimarsana News

Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2024 Earnings Call Transcript

Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics' Call to discuss its First Quarter 2024 Financial Results and Business Updates.

Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates - Vimarsana News

Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

Longer follow up and subset analyses from the pivotal FELIX Phase 2 data to be presented in oral presentations at ASCO and EHATwo patients enrolled in Phase 1 Systemic Lupus Erythematosus trial;...

Autolus reports Q1 2024 Financial Results | Company Announcement - Vimarsana News

Autolus reports Q1 2024 Financial Results | Company Announcement

Investegate announcements from Autolus reports Q1 2024 Financial Results

Syncona : Autolus Therapeutics Announces Changes to its Board of Directors (1) -April 02, 2024 at 04:17 am EDT - Vimarsana News

Syncona : Autolus Therapeutics Announces Changes to its Board of Directors (1) -April 02, 2024 at 04:17 am EDT

Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces the appointment of Mike Bonney as Chairman of the...